Current evidence supports facial fat grafting for selected volume restoration, but it does not justify describing fat as a universal regenerative treatment. Research on nanofat and cell-enriched preparations is promising in narrow settings, yet study size, processing methods and outcome measures remain inconsistent.
Routine practice and experimental strategies are different
| Approach | Current role | Main uncertainty |
|---|---|---|
| Microfat | Selected structural volume restoration | Variable retention and possible refinement |
| Nanofat | Selected superficial skin-quality indications | Magnitude and duration of visible benefit |
| Cell-enriched grafting | Research or regulated use in some jurisdictions | Processing, regulation, cost and long-term evidence |
| Laboratory-expanded cells | Experimental or specifically regulated applications | Should not be marketed as routine facial rejuvenation |
Microfat restores volume when the diagnosis is volume loss
Microfat can soften measured hollows in the temples, forehead, upper-eyelid A-frame, lid–cheek transition and selected cheek or perioral areas. It cannot reliably reposition a descended brow, correct true ptosis, remove orbital-fat bags, treat jowls or redefine a lax neck.
Retention varies with vascularity, recipient plane, deposit size, tissue quality, weight and healing. Imaging studies confirm that graft volume changes over time, so universal survival percentages and permanent-volume guarantees are not credible.
Nanofat evidence remains indication-specific
Nanofat is mechanically processed into a fine suspension and does not function as a structural volumizer. A randomized clinical study of 15 patients reported improvement in measured fine-wrinkle parameters at seven months. The small sample and limited design mean that the result cannot be generalized to every facial region, pigmentation problem or skin type.
Clinical benefit in one setting does not prove that nanofat lifts tissue, corrects deep folds or reverses aging. Claims about “stem-cell rejuvenation” should distinguish cellular findings from outcomes that patients can see and measure.
Cell enrichment has not become a universal standard
A multicenter randomized study found higher MRI-measured retention with stromal vascular fraction–enriched fat than with conventional grafting at 6 and 24 weeks. The trial enrolled 23 participants, and patient-evaluated aesthetic scores did not differ significantly between groups.
This is useful research, but it does not establish that cell-enriched processing is necessary for routine facial grafting. Regulation, laboratory handling, cost, reproducibility and long-term safety must be considered before translating a research protocol into clinical marketing.
Better evidence should answer practical questions
- Which processing method improves a patient-relevant outcome?
- Does benefit persist beyond the early recovery period?
- Which facial regions and recipient planes respond best?
- How do weight change, age and previous injectables alter retention?
- Are complication rates reported with enough follow-up?
Prior injectables and anatomy still govern candidacy
Hyaluronic-acid fillers, biostimulators, threads, PMMA, silicone and devices can alter tissue planes, volume and edema. Dermatologic ultrasound may be required before grafting. Hyaluronidase acts on hyaluronic acid only and does not remove permanent material, fibrosis or transferred fat.
When descent is the main problem, Hybrid Blepharoplasty, video-assisted surgery, facelift or neck treatment may be more appropriate. Fat can complement repositioning, but it should not be used to avoid a diagnosis.
International care requires an established procedure, not a research promise
The final indication is confirmed after in-person examination. Major combined facial procedures are performed at Hospital São José, with structured postoperative review. The Concierge supports accommodation and transport without replacing medical monitoring.
Related reading: nanofat evidence and limitations and facial fat-grafting indications and recovery.
